Drew Ranieri

Stock Analyst at Morgan Stanley

(1.24)
# 3,586
Out of 4,902 analysts
167
Total ratings
45.56%
Success rate
-12.59%
Average return

Stocks Rated by Drew Ranieri

Globus Medical
Jul 15, 2025
Maintains: Overweight
Price Target: $75$68
Current: $57.55
Upside: +18.16%
Organogenesis Holdings
Mar 5, 2025
Maintains: Equal-Weight
Price Target: $4$6
Current: $4.36
Upside: +37.61%
Alphatec Holdings
Dec 2, 2024
Assumes: Equal-Weight
Price Target: $9.5$10
Current: $10.63
Upside: -5.93%
Stryker
Dec 2, 2024
Upgrades: Overweight
Price Target: $370$445
Current: $388.90
Upside: +14.43%
SI-BONE
Aug 6, 2024
Maintains: Overweight
Price Target: $21$19
Current: $16.75
Upside: +13.43%
Integra LifeSciences Holdings
Jul 15, 2024
Maintains: Underweight
Price Target: $24$27
Current: $11.98
Upside: +125.38%
Treace Medical Concepts
Jul 15, 2024
Maintains: Equal-Weight
Price Target: $5.5$8
Current: $5.79
Upside: +38.17%
Stevanato Group
Jul 15, 2024
Maintains: Equal-Weight
Price Target: $26$22
Current: $25.49
Upside: -13.69%
NeuroPace
Jul 15, 2024
Maintains: Equal-Weight
Price Target: $9.5$8
Current: $9.08
Upside: -11.89%
Outset Medical
Dec 4, 2023
Maintains: Equal-Weight
Price Target: $75$83
Current: $17.60
Upside: +368.75%
Maintains: Overweight
Price Target: $42$38
Current: $19.75
Upside: +92.41%
Maintains: Equal-Weight
Price Target: $88$96
Current: $73.45
Upside: +30.70%
Maintains: Underweight
Price Target: $28$26
Current: $11.64
Upside: +123.37%
Maintains: Overweight
Price Target: $290$295
Current: $180.90
Upside: +63.07%
Maintains: Equal-Weight
Price Target: $236$280
Current: $113.59
Upside: +146.50%
Maintains: Overweight
Price Target: $11$5
Current: $6.49
Upside: -22.96%
Maintains: Overweight
Price Target: $72$70
Current: $27.89
Upside: +150.99%
Maintains: Equal-Weight
Price Target: $325$300
Current: $516.16
Upside: -41.88%